Glyburide and Carisoprodol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glyburide (glyburide) and Carisoprodol (carisoprodol). Common drug interactions include emotional distress among females and completed suicide among males.

The phase IV clinical study analyzes what interactions people have when they take Glyburide and Carisoprodol. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Glyburide?

Glyburide has active ingredients of glyburide. It is often used in diabetes. eHealthMe is studying from 38,448 Glyburide users. Check the latest studies of Glyburide.

What is Carisoprodol?

Carisoprodol has active ingredients of carisoprodol. It is often used in muscle spasms. eHealthMe is studying from 3,600 Carisoprodol users. Check the latest studies of Carisoprodol.



On Jul, 12, 2026

42 people who take Glyburide and Carisoprodol together, and have interactions are studied.

Glyburide and Carisoprodol drug interactions.

What are the common drug interactions of Glyburide and Carisoprodol, by gender? *:

female:

  1. Emotional distress
  2. Fall
  3. Infection
  4. Influenza
  5. Injection site pain
  6. Injury
  7. Intervertebral disc degeneration (spinal disc degeneration)
  8. Neck pain
  9. Pain in extremity
  10. Pneumonia

male:

  1. Completed suicide (act of taking one's own life)
  2. Chronic kidney disease
  3. Prostatitis (inflammation of the prostate gland)
  4. Vision blurred
  5. Weight decreased
  6. Atrioventricular block complete (heart block complete)
  7. Death
  8. Decreased appetite
  9. Heart rate increased
  10. Hypertension (high blood pressure)

What are the common drug interactions of Glyburide and Carisoprodol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Completed suicide (act of taking one's own life)
  2. Chronic kidney disease
  3. Death
  4. Poisoning

50-59:

  1. Hepatic steatosis (fatty liver disease)
  2. Hypertension (high blood pressure)
  3. Injection site pain
  4. Lactic acidosis (low ph in body tissues)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Neuropathy peripheral (surface nerve damage)
  7. Obesity (having too much body fat)
  8. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
  9. Oedema peripheral (superficial swelling)
  10. Orthopnoea (shortness of breath (dyspnea) when lying down)

60+:

  1. Chronic kidney disease
  2. Anxiety
  3. Anaemia (lack of blood)
  4. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  5. Aphasia (damage to the parts of the brain that control language)
  6. Asbestosis (chronic lung disease caused by scarring of lung tissue, which stems from prolonged exposure to asbestos)
  7. Asthenia (weakness)
  8. Balance disorder
  9. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  10. Blindness transient (sudden loss of vision)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 30.95%
  2. Pain: 10 people, 23.81%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 14.29%
  4. High Blood Cholesterol: 5 people, 11.90%
  5. High Blood Pressure: 5 people, 11.90%
  6. Pneumonia: 4 people, 9.52%
  7. Infection: 4 people, 9.52%
  8. Joint Pain: 4 people, 9.52%
  9. Depression: 4 people, 9.52%
  10. Indigestion: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Glyburide and Carisoprodol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glyburide and Carisoprodol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glyburide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Carisoprodol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glyburide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carisoprodol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glyburide and carisoprodol (the active ingredients of Glyburide and Carisoprodol, respectively), and Glyburide and Carisoprodol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: